Label Value
DOI 10.1007/s11060-018-2975-5
TITLE Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus Yes 2018-09-02T02:26:37.619571
Web of Science Yes 2018-12-05T03:43:27.581147
Compendex No 2019-12-19T07:06:16.318906